Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.injury.2011.03.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Revising the null model in language evolution research.
Behav Brain Sci
January 2025
Department of Experimental Linguistics, Centre for Language Evolution Studies, Nicolaus Copernicus University in Toruń, Toruń,
We comment on the consequences of the target article for language evolution research. We propose that the default assumption should be that of language-readiness in extinct hominins, and the integration of different types of available evidence from multiple disciplines should be used to assess the likely extent of the realization of this readiness. The role of archaeological evidence should be reconsidered.
View Article and Find Full Text PDFComment on: "Measured glomerular filtration rate based on iohexol: Towards an application in liver transplantation.".
Dig Liver Dis
January 2025
Service d'Hépato-gastroentérologie. CHU Dupuytren. 2, avenue Martin Luther Ling. 87042 Limoges. France; Unité Mixte de Recherche UMR-1248 « Pharmacologie et Transplantation », Faculté de Médecine et de Pharmacie, Université de Limoges. 2, rue du Dr Marcland, 87024 Limoges, France.
Limitation of life-sustaining treatments in Asian ICUs: theory versus practice.
Crit Care
January 2025
Division of Respiratory and Critical Care Medicine, Department of Medicine, National University Hospital, National University Health System, Singapore, Singapore.
Utilizing the ultrasonic shear for internal mammary artery harvesting in minimally invasive coronary artery bypass grafting surgery is worth considering.
J Thorac Dis
November 2024
Department of Cardiac Surgery, Peking University Third Hospital, Beijing, China.
Three vs 6 Cycles of Chemotherapy for High-Risk Retinoblastoma: A Randomized Clinical Trial.
JAMA
November 2024
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China.
Article Synopsis
- Adjuvant therapy, specifically CEV chemotherapy, is crucial for treating high-risk unilateral retinoblastoma, but there hasn't been sufficient comparison between administering 3 vs. 6 cycles of this treatment.
- A randomized trial involving 187 patients aimed to determine if 3 cycles of CEV chemotherapy is as effective as 6 cycles in terms of disease-free survival after enucleation.
- The results showed that the 3-cycle regimen had comparable disease-free survival rates and was associated with fewer adverse events and lower costs, suggesting it could be a more efficient treatment option.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!